Company Search:
Advanced Search
Sponsored Links
Sanochemia Pharmazeutika AG Company Snapshot
Sanochemia Pharmazeutika AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sanochemia Pharmazeutika AG with three other pharmaceutical manufacturers in Europe: Biosynex SA of France (2018 sales of 31.21 million Euro [US$34.45 million] of which 56% was Sale of Goods), Summit Therapeutics PLC of the United Kingdom (£25.42 million [US$32.14 million] of which 100% was Drug Discovery), and Les Trois Chenes which is based in France (35.45 million Euro [US$39.12 million] ).

Sales Analysis. During the year ended September of 2018, sales at Sanochemia Pharmazeutika AG were 33.03 million Euro (US$36.45 million). This is a decrease of 20.2% versus 2017, when the company's sales were 41.36 million Euro. The sales level in 2018 was fairly close to the level five years ago: in 2013, Sanochemia Pharmazeutika AG had sales of 33.30 million Euro. Contributing to the drop in overall sales was the 38.5% decline in Production, from 7.85 million Euro to 4.83 million Euro. There were also decreases in sales in Human Pharmaceuticals (down 20.6% to 21.07 million Euro) and Veterinary Pharmaceuticals (down 26.2% to 4.86 million Euro) . However, these declines were partially offset by the increase in sales of R&d (up 617.7% to 3.09 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sanochemia Pharmazeutika AG
  Stock Performance Chart for Sanochemia Pharmazeutika AG
  Stock Data: Recent Stock Performance:
  Current Price (10/10/2019): 1.77
(Figures in Euro)
1 Week -3.3%   13 Weeks 0.0%  
4 Weeks -4.3%   52 Weeks 15.7%  
Sanochemia Pharmazeutika AG Key Data:
  Ticker: SAC Country: Austria
  Exchanges: DUS FRA VIE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 33,026,000
(Year Ending Jan 2019).
Employees: 153
  Currency: Euro Market Cap: 27,700,201
  Fiscal Yr Ends: September Shares Outstanding: 15,649,831
  Share Type: Stammaktie Closely Held Shares: 7,465,991
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.